Analysts classified the Biontech paper in the past month.
The Biontech (ADRS) share was analyzed by 2 experts in January 2025.
1 expert recommends the share to buy, 1 expert recommends keeping the Biontech (ADRS) share.
The average price target of the analysts is $ 128.50. This means an expected increase of $ 4.80 to the current NAS course of Biontech (ADRS) share of USD 123.70.
The 6-month rating trend is on Buy.
| Analyst | Price target | Distance target | Date | |
|---|---|---|---|---|
| JP Morgan Chase & Co. | USD 120.00 | -2.99 | 01/27/2025 | |
| Goldman Sachs Group Inc. | USD 137.00 | 10.75 | 01/15/2025 |
Editor finance.net
Selected leverage products on Biontech (ADRS)
With knock-outs, speculative investors can participate disproportionately in price movements. Simply choose the desired lever and we will show you suitable open-end products on Biontech (ADRS)
The lever must be between 2 and 20
Advertising